Kaival Brands Commends Recent FDA Regulation Efforts

<p>FDA Scientific Reviews of Certain PMTAs Expected by December 2023 GRANT-VALKARIA, Fla., Aug. 30, 2023 (GLOBE NEWSWIRE) — Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) (“Kaival Brands,” the “Company,” or “we”), the exclusive U.S. distributor of all products manufactured by Bidi Vapor, LLC (“Bidi Vapor”), which are intended for adults 21 and over, today provided […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/kaival-brands-commends-recent-fda-regulation-efforts/">Kaival Brands Commends Recent FDA Regulation Efforts</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>